Single cell RNA sequencing for longitudinal human peripheral blood from HR+ breast cancer patients treated with immunotherapy
Single-cell RNA-seq · human · 32 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 25 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patientsNPJ breast cancer · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE300475_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1281033 and SRA study SRP594088. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 32 sample titles: 25 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9061665 scRNAseq PT1
- GSM9061666 scRNAseq PT6
- GSM9061667 scRNAseq PT7
- GSM9061668 scRNAseq PT13
- GSM9061669 scRNAseq PT15
- GSM9061670 scRNAseq Week3
- GSM9061671 scRNAseq Week3_addition
- GSM9061672 scRNAseq PT15_add
- GSM9061673 scRNAseq PT11
- GSM9061674 scRNAseq PT5
- GSM9061675 scRNAseq Week1
- GSM9061676 scRNAseq PT1_HTO
- GSM9061677 scRNAseq PT6_HTO
- GSM9061678 scRNAseq PT7_HTO
- GSM9061679 scRNAseq PT13_HTO
- GSM9061680 scRNAseq PT15_HTO
- GSM9061681 scRNAseq Week3_HTO
- GSM9061682 scRNAseq Week3_addition_HTO
- GSM9061683 scRNAseq PT15_replicate_HTO
- GSM9061684 scRNAseq PT11_HTO
- GSM9061685 scRNAseq PT5_HTO
- GSM9061686 scRNAseq Week1_HTO
- GSM9061687 scRNAseq PT1_VDJ
- GSM9061688 scRNAseq PT6_VDJ
- GSM9061689 scRNAseq PT7_VDJ
- GSM9061690 scRNAseq PT13_VDJ
- GSM9061691 scRNAseq PT15_VDJ
- GSM9061692 scRNAseq Week3_VDJ
- GSM9061693 scRNAseq Week3_addition_VDJ
- GSM9061694 scRNAseq PT11_VDJ
- GSM9061695 scRNAseq PT5_VDJ
- GSM9061696 scRNAseq Week1_VDJ
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE289582 Baseline tumor features and peripheral blood immune dynamics that underlie efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumab [Blood] 115 samples shares peripheral, treated, blood
- GSE263995 Gene expression at single cell level of tumor-infiltrating cells from the tumor foci, draining lymph node and peripheral blood of triple-negative breast cancer 14 samples shares peripheral, breast, blood
- GSE253173 Coupling of response biomarkers between tumour and peripheral blood in patients undergoing chemoimmunotherapy II 100 samples shares immunotherapy, peripheral, blood
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.